Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid phase concentrated growth factors vs 2% lidocaine for myofascial pain syndrome
IRCT20220610055126N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine in chronic myofascial pain (CMP) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Jun 2022; status: completed.
02
Drugs
lidocaine
03
Conditions
chronic myofascial pain (CMP)
Beyond the preview
Go deeper on IRCT20220610055126N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220610055126N1.